Evidence map›Paper›PMID 31614993›Full record

ReviewPolymers2019

Antimicrobial Activity and Mechanism of Functionalized Quantum Dots.

Keerthiga Rajendiran, Zizhen Zhao, De-Sheng Pei, Ailing Fu

Open access · goldAbstract readReview
In one paragraph

Review in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Antibacterial Coating Based on Functionalized MoSMaterials (Basel, Switzerland) · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. New emerging materials with potential antibacterial activities.Applied microbiology and biotechnology · 2024
    Review
  13. Article
  14. Quantum dots for bone tissue engineering.Materials today. Bio · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Keerthiga RajendiranCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China. keerthikesh@gmail.com.ORCID 0000-0002-5119-770X
Zizhen ZhaoCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China. w.joe@163.com.
De-Sheng PeiChongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing 400714, China. peids@cigit.ac.cn.ORCID 0000-0001-6408-9575
Ailing FuCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China. fal@swu.edu.cn.
Southwest University · CNChongqing Institute of Green and Intelligent Technology · CN

Funding

Natural Science Foundation of Chongqing cstc2018jcyjAX0612
6 · The paper itself

Abstract

An essential characteristic of quantum dots (QDs) is their antimicrobial activity. Compared with conventional antibiotics, QDs not only possess photoluminescence properties for imaging and photodynamic therapy but also have high structural stability. To enhance their antimicrobial efficiency, QDs usually are functionalized by polymers, including poly(ethylene glycol), polyethyleneimine, and poly-l-lysine. Also, QDs conjugated with polymers, such as poly(vinylpyrrolidone) and polyvinylidene fluoride, are prepared as antimicrobial membranes. The main antimicrobial mechanisms of QDs are associated with inducing free radicals, disrupting cell walls/membranes, and arresting gene expression. The different mechanisms from traditional antibiotics allow QDs to play antimicrobial roles in multi-drug-resistant bacteria and fungi. Since the toxicity of the QDs on animal cells is relatively low, they have broad application in antimicrobial research as an effective alternative of traditional antibiotics.

Indexed as

antimicrobial efficiencymulti-drug resistancequantum dotsreactive oxygen species (ROS)

Identifiers

PMID31614993
PMCPMC6835343
OpenAlexW2979531034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.